Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cellsNAKAMURA, Motoyuki; KIKUCHI, Tetsuro; KUFE, Donald W et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 8, pp 690-696, issn 0340-7004, 7 p.Article

Molecular targeting of gene therapy and radiotherapyWEICHSELBAUM, Ralph R; KUFE, Donald W; ADVANI, Sunil J et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 6, pp 735-738, issn 0284-186XConference Paper

Transcriptional targeting of adenovirally delivered tumor necrosis factor α by temozolomide in experimental glioblastomaYAMINI, Bakhtiar; XIAOHONG YU; GILLESPIE, G. Yancey et al.Cancer research (Baltimore). 2004, Vol 64, Num 18, pp 6381-6384, issn 0008-5472, 4 p.Article

Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibodyAKEWANLOP, Charuwan; WATANABE, Michiaki; SINGH, Baljit et al.Cancer research (Baltimore). 2001, Vol 61, Num 10, pp 4061-4065, issn 0008-5472Article

MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung CancerKHODAREV, Nikolai N; PITRODA, Sean P; BECKETT, Michael A et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 2833-2837, issn 0008-5472, 5 p.Article

A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusionSUPKO, Jeffrey G; LYNCH, Thomas J; CLARK, Jeffrey W et al.Cancer chemotherapy and pharmacology. 2000, Vol 46, Num 4, pp 319-328, issn 0344-5704Article

Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumorsSUPKO, Jeffrey G; EDER, Joseph P; RYAN, David P et al.Clinical cancer research. 2003, Vol 9, Num 14, pp 5178-5186, issn 1078-0432, 9 p.Article

Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membraneEPPERLY, Michael W; SIKORA, Christine A; DEFILIPPI, Stacy J et al.Radiation research. 2002, Vol 157, Num 5, pp 568-577, issn 0033-7587, 10 p.Article

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12KIKUCHI, Tetsuro; AKASAKI, Yasuharu; ABE, Toshiaki et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 6, pp 452-459, issn 1524-9557, 8 p.Article

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated dailyEDER, Joseph P; SUPKO, Jeffrey G; CONNORS, Susan et al.Journal of clinical oncology. 2002, Vol 20, Num 18, pp 3772-3784, issn 0732-183X, SUPArticle

Tumor production of angiostatin is enhanced after exposure to TNF-αMAUCERI, Helena J; SEETHARAM, Saraswathy; WEICHSELBAUM, Ralph R et al.International journal of cancer. 2002, Vol 97, Num 4, pp 410-415, issn 0020-7136Article

NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicitySALLOUM, Rabih M; JASKOWIAK, Nora T; POSNER, Mitchell C et al.Cancer research (Baltimore). 2000, Vol 60, Num 24, pp 6958-6963, issn 0008-5472Article

Inhibition of nuclear factor-κB activity by temozolomide involves O⁶-methylguanine -induced inhibition of p65 DNA bindingYAMINI, Bakhtiar; XIAOHONG YU; EILEEN DOLAN, M et al.Cancer research (Baltimore). 2007, Vol 67, Num 14, pp 6889-6898, issn 0008-5472, 10 p.Article

Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinomaMURPHY, Kevin T; WARDAK, Abdullah; KUFE, Donald W et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 3, pp 317-321, issn 0344-5704, 5 p.Article

A phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremitiesMUNDT, Arno J; VIJAYAKUMAR, Srinivasan; KESSLER, Paul D et al.Clinical cancer research. 2004, Vol 10, Num 17, pp 5747-5753, issn 1078-0432, 7 p.Article